Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Cintas Is A Good Long Term Holding, Thanks To Organic Growth: Analyst

Published 27/09/2023, 20:51
© Reuters.  Cintas Is A Good Long Term Holding, Thanks To Organic Growth: Analyst
CTAS
-

Benzinga - by Nabaparna Bhattacharya, Benzinga Editor.

Stifel analyst Shlomo H. Rosenbaum reiterated the Hold rating on Cintas Corporation (NASDAQ: CTAS), raising the price target to $526 from $521.

CTAS reported first-quarter FY24 revenue growth of 8% year-on-year to $2.34 billion, meeting the analyst consensus estimate. The organic revenue growth rate, which adjusts for the impacts of acquisitions and foreign currency exchange rate fluctuations, was 8.1% for the quarter.

The analyst views the earnings report as solid. CTAS is typically a "beat and raise" stock, and investors have come to expect a beat and a raise in the quarter, notes the analyst.

Rosenbaum is bullish on the company's track record of growth and margin improvement and believes that management likes to set targets that it can at least deliver upon and hopefully (and generally) outperform against. CTAS is unique in terms of being the largest company in the space but still having the fastest organic growth rate, the analyst adds.

While Rosenbaum thinks that the stock is a good holding for the long term, the current valuation captures the bulk of the appreciation potential in the near term.

While there might be a slowdown in the macro environment at some point in the future that impacts CTAS, CTAS has not seen any meaningful changes in customer behavior since the last earnings report.

The analyst believes the largest macro risk would be rising unemployment, which could represent a headwind to both revenue (less wearers per stop) and margins.

For FY24, the analyst now expects EPS of $14.46, while for FY25, Rosenbaum projects an EPS of $16.02.

Price Action: CTAS shares are trading higher by 0.44% to $481.36 on the last check Wednesday.

Latest Ratings for CTAS

DateFirmActionFromTo
Jan 2022Morgan StanleyMaintainsEqual-Weight
Dec 2021Argus ResearchMaintainsBuy
Dec 2021Morgan StanleyMaintainsEqual-Weight
View More Analyst Ratings for CTAS

View the Latest Analyst Ratings

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.